Delivery Order SPE2DB24D9238-SPE2DB25FDQYD
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for YF-VAX 1 dose vials with a ceiling value of $2,226.84. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 15, 2025, and will be performed at the vendor's Park Ridge location. The award falls under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,670.13 by the Defense Logistics Agency for the supply of YF-VAX 1 Dose Vials. This firm fixed-price delivery order, issued on July 24, 2025, carries an ultimate completion date of August 14, 2025, with no set-aside designation applied to the award. The contract represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,340.26 by the Defense Logistics Agency for YF-VAX 1 dose vials. The contract was awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, and carries firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,226.84 by the Defense Logistics Agency on July 21, 2025, for the supply of YF-VAX 1 dose vials. The award utilizes a firm fixed-price delivery order contract type with no set-aside designation, and performance is scheduled for completion by August 11, 2025, at the contractor's Park Ridge facility. This delivery order falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,701.30 by the Defense Logistics Agency on August 11, 2025, for the supply of YF-VAX 1 dose vials. This delivery order, with an ultimate completion date of September 2, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. The award represents a discrete purchase...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of YF-VAX 1 Dose Vials. This delivery order, valued at $2,783.55 with an ultimate completion date of August 11, 2025, was issued without a set-aside designation. The contract represents a discrete delivery against DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials with a ceiling value of $5,567.10. This firm fixed-price delivery order, issued on August 8, 2025, falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. The contract carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $27,835.50 by the Defense Logistics Agency for YF-VAX 1 dose vials. The contract is firm fixed price with no set-aside designation, reflecting the company's competitive standing in federal procurement. The delivery order is set for ultimate completion by August 15, 2025, with performance to take place at the vendor's Park Ridge, Illinois...
- The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for one dose vials of YF-VAX vaccine. The contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.99...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQYDDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,670.13 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, was awarded without a set-aside designation. The delivery order represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain, leveraging its existing Indefinite Delivery Contract with the DLA under the SPE2DB program valued at $499,999,999 through November 2026. The YF-VAX vaccine delivery aligns with the DLA's mission to support medical supply needs across Department of Defense healthcare facilities. DMS Pharmaceutical Group's contract portfolio demonstrates consistent success in securing pharmaceutical distribution awards covering vaccines, prescription medications, biologics, and medical consumables for military health facilities nationwide. The company's established presence in federal procurement since its SAM.gov registration in 2001, combined with its woman-owned small business status, positions it as a reliable supplier for specialized pharmaceutical products required by the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/4/25 |